Fibrin gels are attractive
biomaterials for local delivery of a variety of agents, from drugs to
proteins. Similarly,
polymer-anticancer-
drug conjugates and nanoparticles are emerging as potential candidates for
cancer treatment. Combining these different approaches, we have studied the efficacy of
fibrin gels loaded with
cisplatin (DDP) and a complex of DDP with hyaluronate (DDP-HA) for
tumor growth inhibition in a
melanoma model. Loaded
gels prepared at relatively high
fibrinogen concentration (22 mg/ml) showed good in vitro antiproliferative activities, prolonged release of the anticancer
drug, and a long persistence (10-15 days) in vivo when implanted subcutaneously (sc) in immunodeficient mice.
Gels loaded with DDP or DDP-HA containing 1/3 or even 1/6 of their systemic dose (6 mg/kg) and positioned under the
tumor mass in mice bearing a sc human SK-Mel-28
tumor showed an antitumor activity better than that of the original parent compound given intraperitoneally (ip). Moreover, in an additional experiment in vivo,
fibrin gels loaded with
N-trimethyl chitosan-based nanoparticles containing a DDP-HA complex were assayed, resulting in a further 8 % improvement of anticancer activity, with lesser adverse systemic toxic effects. Taken together, these results suggest that the combination of
fibrin gels and drugs complexed with suitable macromolecules holds great promise for loco-regional anticancer
therapy of
melanoma and other surgically removable
cancer types.